Last reviewed · How we verify
suspected Parkinsonian syndromes
Approved treatments
- Ioflupane I 123 · Ge Hlthcare Inc
Ioflupane I-123 binds to the dopamine transporter (DaT) in the striatum, allowing visualization of brain striata through SPECT imaging.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- suspected Parkinsonian syndromes patent landscape — cliff calendar, originator estates, attackable patents
- suspected Parkinsonian syndromes treatment landscape brief
- suspected Parkinsonian syndromes treatment updates RSS
Frequently asked questions about suspected Parkinsonian syndromes
What drugs treat suspected Parkinsonian syndromes?
Tracked treatments include Ioflupane I 123.
What is the treatment for suspected Parkinsonian syndromes?
Standard treatment for suspected Parkinsonian syndromes includes Ioflupane I 123. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: suspected Parkinsonian syndromes patent cliff · suspected Parkinsonian syndromes CI report
- Treatment: Ioflupane I 123 · Ge Hlthcare Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing